Chair: L. Carrier (Hamburg), S. Steffens (München)
| 16:00 | (V999) | Introduction |
| L. Carrier (Hamburg) | ||
| 16:05 | (V1000) | Emerging Mechanisms in Diabetic Cardiomyopathy |
| H. Bugger (Graz, AT) | ||
| 16:20 | Diskussion | |
| 16:25 | (V1001) | Targeting O-GlcNAcylation to prevent cardiac hypertrophy |
| L. Bertrand (Woluwé-Saint-Lambert, BE) | ||
| 16:40 | Diskussion | |
| 16:45 | (V1002) | Redox signaling in heart failure |
| C. Maack (Würzburg) | ||
| 17:00 | Diskussion | |
| 17:05 | (V1003) | Pathophysiological changes in cardiac lipid metabolism |
| U. Kintscher (Berlin) | ||
| 17:20 | Diskussion | |
| 17:25 | (V1004) | Conclusion |
| S. Steffens (München) |
| 17:45 - 19:45 | Opening Ceremony in hall 4 |